Azalie Armknecht
Adult Medicine · Branson, MONPI 1629785506
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Globus Medical at 39.7% of the total. 2025 is the largest year on record at $726, more than ten times the $56 reported in 2023.
Across 36 payments — averaging $24.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Globus Medical$344
- Sanofi$114
- SPR Therapeutics, Inc$111
- Protega Pharmaceutials Inc$56
- Collegium Pharmaceutical, Inc.$44
- Nevro Corp.$40
- plus $156 from 8 others
What the payments were for
- Food & beverage$866100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Globus Medical | 11 | $344 |
| Sanofi | 4 | $114 |
| SPR Therapeutics, Inc | 6 | $111 |
| Protega Pharmaceutials Inc | 3 | $56 |
| Collegium Pharmaceutical, Inc. | 2 | $44 |
| Nevro Corp. | 2 | $40 |
| EMD Serono, Inc. | 1 | $27 |
| Harmony Biosciences LLC | 1 | $25 |
| AbbVie | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $19 |
| Vertex | 1 | $18 |
| Medtronic | 1 | $14 |
| Metacel Pharmaceuticals LLC | 1 | $12 |
How this compares
Too few adult medicine providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 285 | $5,734 |
| Cyclobenzaprine Hcl | 124 | $1,772 |
| Duloxetine Hcl | 82 | $1,522 |
| Baclofen | 64 | $1,292 |
| Tizanidine Hcl | 107 | $1,029 |
| Celecoxib | 19 | $768 |
| Lamotrigine | 35 | $576 |
| Methocarbamol | 27 | $557 |
| Diclofenac Sodium | 18 | $476 |
| Amitriptyline Hcl | 43 | $457 |
| Ropinirole Hcl | 17 | $352 |
| Meloxicam | 52 | $305 |
| Topiramate | 31 | $209 |
| Trazodone Hcl | 18 | $178 |
| Dexamethasone | 29 | $166 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Branson
- Stefan ScheidlerKennett$5K
- Barbara ObrienEllisville$1K
- Shelly HouseIndependence$959
- Lauren RileyBlue Springs$815
- Michael ColeSaint Louis$317
- Madhuri SubbaiahSaint Louis$296
- Samuel EvansWest Plains$248
- David RyanTrenton$239
- Mahrukh KhanSt. Louis$238
- Eduard RasputkovKirksville$214
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.